AXGN
HealthcareAxoGen, Inc.
$32.26+0.50 (+1.57%)
Prev Close
$31.76
Open
$31.76
High
$33.88
Low
$31.62
Volume
772.3K
Market Cap
$1.53B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at AxoGen, Inc. (AXGN) has been exclusively selling, with 0 insider purchases totaling $0.00 and 30 insider sales totaling $14.48M. The most recent insider transaction was by Weiler Kathy Johnson (Director), who sold $1.38M worth of shares on Dec 16, 2025. AxoGen, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $1.53B.
Buys (12M)
0
$0.00
Sells (12M)
30
$14.48M
Net Activity
Net Seller
$14.48M
Active Insiders
13
last 12 mo
AXGN Price Chart
AXGN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025↗ | Weiler Kathy Johnson | Director | Sell | 46,653 | $29.55 | $1.38M | 0 |
| Dec 16, 2025↗ | Wendell Amy McBride | Director | Sell | 43,684 | $29.31 | $1.28M | 0 |
| Dec 15, 2025↗ | Hartley Lindsey Marie | CFO | Sell | 14,812 | $29.86 | $442.3K | 0 |
| Dec 11, 2025↗ | Began Marc A | EVP & General Counsel | Sell | 13,222 | $30.00 | $396.7K | 0 |
| Dec 10, 2025↗ | DALE MICHAEL D | Chief Executive Officer | Sell | 25,000 | $30.00 | $750.0K | 0 |
| Dec 9, 2025↗ | Began Marc A | EVP & General Counsel | Sell | 9,278 | $31.21 | $289.5K | 0 |
| Dec 9, 2025↗ | DALE MICHAEL D | Chief Executive Officer | Sell | 61,463 | $31.21 | $1.92M | 0 |
| Dec 9, 2025↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 19,517 | $31.21 | $609.1K | 0 |
| Dec 9, 2025↗ | Kemp Jens | Chief Marketing Officer | Sell | 8,156 | $31.21 | $254.5K | 0 |
| Dec 9, 2025↗ | THOMAS PAUL | Director | Sell | 21,399 | $29.61 | $633.7K | 0 |
| Dec 9, 2025↗ | TYNDALL JOSEPH A. | Director | Sell | 25,108 | $30.98 | $777.8K | 0 |
| Dec 8, 2025↗ | Hartley Lindsey Marie | CFO | Sell | 14,387 | $31.56 | $454.0K | 0 |
| Dec 8, 2025↗ | JOHNSON JOHN | Director | Sell | 45,379 | $30.64 | $1.39M | 0 |
| Nov 10, 2025↗ | Burke William P. Mr. | Director | Sell | 22,818 | $24.01 | $547.9K | 0 |
| Nov 5, 2025↗ | Burke William P. Mr. | Director | Sell | 16,778 | $24.04 | $403.3K | 0 |
| Oct 29, 2025↗ | Burke William P. Mr. | Director | Sell | 58,483 | $21.32 | $1.25M | 0 |
| Oct 22, 2025↗ | Burke William P. Mr. | Director | Sell | 1,457 | $18.02 | $26.3K | 0 |
| Oct 6, 2025↗ | Burke William P. Mr. | Director | Sell | 736 | $18.00 | $13.2K | 0 |
| Oct 2, 2025↗ | Burke William P. Mr. | Director | Sell | 32,191 | $18.14 | $584.1K | 0 |
| Sep 13, 2025↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 1,137 | $16.29 | $18.5K | 0 |
| Jun 10, 2025↗ | TYNDALL JOSEPH A. | Director | Sell | 26,931 | $10.72 | $288.7K | 0 |
| Jun 9, 2025↗ | Burke William P. Mr. | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| Jun 9, 2025↗ | JOHNSON JOHN | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| Jun 9, 2025↗ | Levine Alan M | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| Jun 9, 2025↗ | NEELS GUIDO J | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| Jun 9, 2025↗ | Weiler Kathy Johnson | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| Jun 9, 2025↗ | Wendell Amy McBride | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| May 22, 2025↗ | TYNDALL JOSEPH A. | Director | Sell | 20,062 | $11.20 | $224.7K | 0 |
| May 19, 2025↗ | TYNDALL JOSEPH A. | Director | Sell | 2,525 | $11.63 | $29.4K | 0 |
| Mar 16, 2025↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 15,111 | $17.50 | $264.4K | 0 |
| Mar 4, 2025↗ | Kemp Jens | Chief Marketing Officer | Sell | 4,003 | $18.36 | $73.5K | 0 |
| Mar 3, 2025↗ | Wendell Amy McBride | Director | Sell | 5,000 | $20.02 | $100.1K | 0 |
| Mar 1, 2025↗ | Began Marc A | EVP & General Counsel | Sell | 5,901 | $18.36 | $108.3K | 0 |
| Feb 28, 2025↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 8,296 | $18.35 | $152.2K | 0 |
| Feb 22, 2025↗ | Began Marc A | EVP & General Counsel | Sell | 814 | $16.50 | $13.4K | 0 |
| Feb 22, 2025↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 972 | $16.50 | $16.0K | 0 |
| Feb 22, 2025↗ | Kemp Jens | Chief Marketing Officer | Sell | 814 | $16.49 | $13.4K | 0 |
| Jan 6, 2025↗ | Naor Nir | CFO | Sell | 39,132 | $15.22 | $595.6K | 0 |
| Mar 16, 2024↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 4,578 | $7.68 | $35.2K | 0 |
| Mar 16, 2024↗ | Donovan Michael Patrick | VP Operations | Sell | 6,033 | $7.68 | $46.3K | 0 |
| Mar 16, 2024↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 6,881 | $7.68 | $52.8K | 0 |
| Mar 16, 2024↗ | Zaderej Karen L. | CEO | Sell | 39,280 | $7.68 | $301.7K | 0 |
| Mar 7, 2024↗ | Donovan Michael Patrick | VP Operations | Sell | 36,310 | $8.81 | $319.9K | 0 |
| Mar 7, 2024↗ | Freitag Gregory Gene | Director | Sell | 25,000 | $9.00 | $225.0K | 0 |
| Dec 11, 2023↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 12,500 | $7.50 | $93.8K | 0 |
| Sep 6, 2023↗ | Wendell Amy McBride | Director | Buy | 10,000 | $6.22 | $62.2K | 0 |
| Aug 23, 2023↗ | Burke William P. Mr. | Director | Buy | 10,000 | $6.56 | $65.6K | 0 |
| Aug 16, 2023↗ | NEELS GUIDO J | Director | Buy | 10,000 | $6.11 | $61.1K | 0 |
| Jul 18, 2023↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 864 | $4.04 | $3.5K | 0 |
| Jul 18, 2023↗ | Donovan Michael Patrick | VP Operations | Sell | 1,403 | $4.04 | $5.7K | 0 |
| Jul 18, 2023↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 3,263 | $4.04 | $13.2K | 0 |
| Jul 18, 2023↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 1,403 | $4.04 | $5.7K | 0 |
| Jul 18, 2023↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 1,403 | $4.04 | $5.7K | 0 |
| Jun 1, 2023↗ | Freitag Gregory Gene | Director | Sell | 41,980 | $8.71 | $365.8K | 0 |
| May 23, 2023↗ | Freitag Gregory Gene | Director | Sell | 7,468 | $9.23 | $68.9K | 0 |
| Mar 16, 2023↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 2,769 | $8.27 | $22.9K | 0 |
| Mar 16, 2023↗ | Donovan Michael Patrick | VP Operations | Sell | 2,769 | $8.27 | $22.9K | 0 |
| Mar 16, 2023↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 7,038 | $8.27 | $58.2K | 0 |
| Mar 16, 2023↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 4,270 | $8.27 | $35.3K | 0 |
| Mar 16, 2023↗ | Ottinger Bradley | General Counsel and CCO | Sell | 2,634 | $8.27 | $21.8K | 0 |
| Mar 16, 2023↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 3,907 | $8.27 | $32.3K | 0 |
| Jan 30, 2023↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 42,981 | $9.53 | $409.7K | 0 |
| Jan 25, 2023↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 62,818 | $10.10 | $634.3K | 0 |
| Dec 27, 2022↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 327 | $9.44 | $3.1K | 0 |
| Dec 27, 2022↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 10,971 | $9.44 | $103.6K | 0 |
| Dec 27, 2022↗ | Donovan Michael Patrick | VP Operations | Sell | 286 | $9.44 | $2.7K | 0 |
| Dec 27, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 649 | $9.44 | $6.1K | 0 |
| Dec 27, 2022↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 286 | $9.44 | $2.7K | 0 |
| Dec 27, 2022↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 286 | $9.44 | $2.7K | 0 |
| Dec 14, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 8,930 | $10.93 | $97.6K | 0 |
| Nov 16, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 10,649 | $11.88 | $126.5K | 0 |
| Nov 14, 2022↗ | Freitag Gregory Gene | Director | Sell | 13,000 | $12.74 | $165.6K | 0 |
| Nov 8, 2022↗ | Freitag Gregory Gene | Director | Sell | 13,000 | $12.50 | $162.5K | 0 |
| Aug 10, 2022↗ | Freitag Gregory Gene | Director | Sell | 8,886 | $9.70 | $86.2K | 0 |
| Aug 4, 2022↗ | Freitag Gregory Gene | Director | Sell | 37,046 | $10.54 | $390.6K | 0 |
| Jul 25, 2022↗ | Freitag Gregory Gene | Director | Sell | 30,296 | $9.26 | $280.5K | 0 |
| Jul 18, 2022↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 751 | $8.40 | $6.3K | 0 |
| Jul 18, 2022↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 405 | $8.40 | $3.4K | 0 |
| Jul 18, 2022↗ | Donovan Michael Patrick | VP Operations | Sell | 657 | $8.40 | $5.5K | 0 |
| Jul 18, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 947 | $8.40 | $8.0K | 0 |
| Jul 18, 2022↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 657 | $8.40 | $5.5K | 0 |
| Jul 18, 2022↗ | Sandberg Eric | Chief Commercial Officer | Sell | 1,125 | $8.40 | $9.4K | 0 |
| Jul 18, 2022↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 657 | $8.40 | $5.5K | 0 |
| Jul 18, 2022↗ | Zaderej Karen L. | CEO | Sell | 9,081 | $8.40 | $76.3K | 0 |
| Mar 16, 2022↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 2,447 | $7.97 | $19.5K | 0 |
| Mar 16, 2022↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 1,497 | $7.97 | $11.9K | 0 |
| Mar 16, 2022↗ | Donovan Michael Patrick | VP Operations | Sell | 1,512 | $7.97 | $12.1K | 0 |
| Mar 16, 2022↗ | Friedman Mark Louis | VP Regulatory Affairs & Policy | Sell | 1,502 | $7.97 | $12.0K | 0 |
| Mar 16, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 2,769 | $7.97 | $22.1K | 0 |
| Mar 16, 2022↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 3,239 | $7.97 | $25.8K | 0 |
| Mar 16, 2022↗ | Ottinger Bradley | General Counsel and CCO | Sell | 648 | $7.97 | $5.2K | 0 |
| Mar 16, 2022↗ | Sandberg Eric | Chief Commercial Officer | Sell | 1,512 | $7.97 | $12.1K | 0 |
| Mar 16, 2022↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 2,770 | $7.97 | $22.1K | 0 |
| Feb 15, 2022↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 447 | $8.42 | $3.8K | 0 |
| Feb 15, 2022↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 357 | $8.42 | $3.0K | 0 |
| Feb 15, 2022↗ | Donovan Michael Patrick | VP Operations | Sell | 205 | $8.42 | $1.7K | 0 |
| Feb 15, 2022↗ | Friedman Mark Louis | VP Regulatory Affairs & Policy | Sell | 357 | $8.42 | $3.0K | 0 |
| Feb 15, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 950 | $8.42 | $8.0K | 0 |
| Feb 15, 2022↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 400 | $8.42 | $3.4K | 0 |
| Feb 15, 2022↗ | Sandberg Eric | Chief Commercial Officer | Sell | 762 | $8.42 | $6.4K | 0 |
| Feb 15, 2022↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 400 | $8.42 | $3.4K | 0 |
| Dec 27, 2021↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 326 | $9.74 | $3.2K | 0 |
| Dec 27, 2021↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 187 | $9.74 | $1.8K | 0 |
| Dec 27, 2021↗ | Donovan Michael Patrick | VP Operations | Sell | 286 | $9.74 | $2.8K | 0 |
| Dec 27, 2021↗ | Friedman Mark Louis | VP Regulatory Affairs & Policy | Sell | 286 | $9.74 | $2.8K | 0 |
| Dec 27, 2021↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 648 | $9.74 | $6.3K | 0 |
| Dec 27, 2021↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 286 | $9.74 | $2.8K | 0 |
| Dec 27, 2021↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 286 | $9.74 | $2.8K | 0 |
| Dec 27, 2021↗ | Zaderej Karen L. | CEO | Sell | 1,752 | $9.74 | $17.1K | 0 |
| Dec 20, 2021↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 144 | $9.24 | $1.3K | 0 |
| Dec 20, 2021↗ | Donovan Michael Patrick | VP Operations | Sell | 95 | $9.24 | $877.80 | 0 |
| Dec 20, 2021↗ | Friedman Mark Louis | VP Regulatory Affairs & Policy | Sell | 95 | $9.24 | $877.80 | 0 |
| Dec 20, 2021↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 757 | $9.24 | $7.0K | 0 |
| Dec 20, 2021↗ | Zaderej Karen L. | CEO | Sell | 1,243 | $9.24 | $11.5K | 0 |
| Dec 15, 2021↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 4,171 | $8.80 | $36.7K | 0 |
| Aug 6, 2021↗ | Zaderej Karen L. | CEO | Sell | 41,000 | $18.47 | $757.2K | 0 |
| Jul 21, 2021↗ | Donovan Michael Patrick | VP Operations | Sell | 1,935 | $20.04 | $38.8K | 0 |
| Jul 19, 2021↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 728 | $19.20 | $14.0K | 0 |
| Jul 19, 2021↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 392 | $19.20 | $7.5K | 0 |
| Jul 19, 2021↗ | Donovan Michael Patrick | VP Operations | Sell | 637 | $19.20 | $12.2K | 0 |
| Jul 19, 2021↗ | Friedman Mark Louis | VP Regulatory Affairs & Policy | Sell | 637 | $19.20 | $12.2K | 0 |
| Jul 19, 2021↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 918 | $19.20 | $17.6K | 0 |
| Jul 19, 2021↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 637 | $19.20 | $12.2K | 0 |
| Jul 19, 2021↗ | Sandberg Eric | Chief Commercial Officer | Sell | 1,090 | $19.20 | $20.9K | 0 |
| Jul 19, 2021↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 637 | $19.20 | $12.2K | 0 |
| Jul 19, 2021↗ | Zaderej Karen L. | CEO | Sell | 8,812 | $19.20 | $169.2K | 0 |
| Jun 17, 2021↗ | Freitag Gregory Gene | Director | Sell | 8,781 | $20.92 | $183.7K | 0 |
| Jun 4, 2021↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 2,652 | $18.86 | $50.0K | 0 |
| Feb 25, 2021↗ | Freitag Gregory Gene | Director | Sell | 24,000 | $22.06 | $529.4K | 0 |
AXGN Insider Buying Activity
The following table shows recent insider purchases of AxoGen, Inc. (AXGN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 6, 2023↗ | Wendell Amy McBride | Director | Buy | 10,000 | $6.22 | $62.2K | 0 |
| Aug 23, 2023↗ | Burke William P. Mr. | Director | Buy | 10,000 | $6.56 | $65.6K | 0 |
| Aug 16, 2023↗ | NEELS GUIDO J | Director | Buy | 10,000 | $6.11 | $61.1K | 0 |
AXGN Insider Selling Activity
The following table shows recent insider sales of AxoGen, Inc. (AXGN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025↗ | Weiler Kathy Johnson | Director | Sell | 46,653 | $29.55 | $1.38M | 0 |
| Dec 16, 2025↗ | Wendell Amy McBride | Director | Sell | 43,684 | $29.31 | $1.28M | 0 |
| Dec 15, 2025↗ | Hartley Lindsey Marie | CFO | Sell | 14,812 | $29.86 | $442.3K | 0 |
| Dec 11, 2025↗ | Began Marc A | EVP & General Counsel | Sell | 13,222 | $30.00 | $396.7K | 0 |
| Dec 10, 2025↗ | DALE MICHAEL D | Chief Executive Officer | Sell | 25,000 | $30.00 | $750.0K | 0 |
| Dec 9, 2025↗ | Began Marc A | EVP & General Counsel | Sell | 9,278 | $31.21 | $289.5K | 0 |
| Dec 9, 2025↗ | DALE MICHAEL D | Chief Executive Officer | Sell | 61,463 | $31.21 | $1.92M | 0 |
| Dec 9, 2025↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 19,517 | $31.21 | $609.1K | 0 |
| Dec 9, 2025↗ | Kemp Jens | Chief Marketing Officer | Sell | 8,156 | $31.21 | $254.5K | 0 |
| Dec 9, 2025↗ | THOMAS PAUL | Director | Sell | 21,399 | $29.61 | $633.7K | 0 |
| Dec 9, 2025↗ | TYNDALL JOSEPH A. | Director | Sell | 25,108 | $30.98 | $777.8K | 0 |
| Dec 8, 2025↗ | Hartley Lindsey Marie | CFO | Sell | 14,387 | $31.56 | $454.0K | 0 |
| Dec 8, 2025↗ | JOHNSON JOHN | Director | Sell | 45,379 | $30.64 | $1.39M | 0 |
| Nov 10, 2025↗ | Burke William P. Mr. | Director | Sell | 22,818 | $24.01 | $547.9K | 0 |
| Nov 5, 2025↗ | Burke William P. Mr. | Director | Sell | 16,778 | $24.04 | $403.3K | 0 |
| Oct 29, 2025↗ | Burke William P. Mr. | Director | Sell | 58,483 | $21.32 | $1.25M | 0 |
| Oct 22, 2025↗ | Burke William P. Mr. | Director | Sell | 1,457 | $18.02 | $26.3K | 0 |
| Oct 6, 2025↗ | Burke William P. Mr. | Director | Sell | 736 | $18.00 | $13.2K | 0 |
| Oct 2, 2025↗ | Burke William P. Mr. | Director | Sell | 32,191 | $18.14 | $584.1K | 0 |
| Sep 13, 2025↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 1,137 | $16.29 | $18.5K | 0 |
| Jun 10, 2025↗ | TYNDALL JOSEPH A. | Director | Sell | 26,931 | $10.72 | $288.7K | 0 |
| Jun 9, 2025↗ | Burke William P. Mr. | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| Jun 9, 2025↗ | JOHNSON JOHN | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| Jun 9, 2025↗ | Levine Alan M | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| Jun 9, 2025↗ | NEELS GUIDO J | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| Jun 9, 2025↗ | Weiler Kathy Johnson | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| Jun 9, 2025↗ | Wendell Amy McBride | Director | Sell | 4,073 | $10.61 | $43.2K | 0 |
| May 22, 2025↗ | TYNDALL JOSEPH A. | Director | Sell | 20,062 | $11.20 | $224.7K | 0 |
| May 19, 2025↗ | TYNDALL JOSEPH A. | Director | Sell | 2,525 | $11.63 | $29.4K | 0 |
| Mar 16, 2025↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 15,111 | $17.50 | $264.4K | 0 |
| Mar 4, 2025↗ | Kemp Jens | Chief Marketing Officer | Sell | 4,003 | $18.36 | $73.5K | 0 |
| Mar 3, 2025↗ | Wendell Amy McBride | Director | Sell | 5,000 | $20.02 | $100.1K | 0 |
| Mar 1, 2025↗ | Began Marc A | EVP & General Counsel | Sell | 5,901 | $18.36 | $108.3K | 0 |
| Feb 28, 2025↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 8,296 | $18.35 | $152.2K | 0 |
| Feb 22, 2025↗ | Began Marc A | EVP & General Counsel | Sell | 814 | $16.50 | $13.4K | 0 |
| Feb 22, 2025↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 972 | $16.50 | $16.0K | 0 |
| Feb 22, 2025↗ | Kemp Jens | Chief Marketing Officer | Sell | 814 | $16.49 | $13.4K | 0 |
| Jan 6, 2025↗ | Naor Nir | CFO | Sell | 39,132 | $15.22 | $595.6K | 0 |
| Mar 16, 2024↗ | DeVinney Erick Wayne | Chief Innovation Officer | Sell | 4,578 | $7.68 | $35.2K | 0 |
| Mar 16, 2024↗ | Donovan Michael Patrick | VP Operations | Sell | 6,033 | $7.68 | $46.3K | 0 |
| Mar 16, 2024↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 6,881 | $7.68 | $52.8K | 0 |
| Mar 16, 2024↗ | Zaderej Karen L. | CEO | Sell | 39,280 | $7.68 | $301.7K | 0 |
| Mar 7, 2024↗ | Donovan Michael Patrick | VP Operations | Sell | 36,310 | $8.81 | $319.9K | 0 |
| Mar 7, 2024↗ | Freitag Gregory Gene | Director | Sell | 25,000 | $9.00 | $225.0K | 0 |
| Dec 11, 2023↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 12,500 | $7.50 | $93.8K | 0 |
| Jul 18, 2023↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 864 | $4.04 | $3.5K | 0 |
| Jul 18, 2023↗ | Donovan Michael Patrick | VP Operations | Sell | 1,403 | $4.04 | $5.7K | 0 |
| Jul 18, 2023↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 3,263 | $4.04 | $13.2K | 0 |
| Jul 18, 2023↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 1,403 | $4.04 | $5.7K | 0 |
| Jul 18, 2023↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 1,403 | $4.04 | $5.7K | 0 |
| Jun 1, 2023↗ | Freitag Gregory Gene | Director | Sell | 41,980 | $8.71 | $365.8K | 0 |
| May 23, 2023↗ | Freitag Gregory Gene | Director | Sell | 7,468 | $9.23 | $68.9K | 0 |
| Mar 16, 2023↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 2,769 | $8.27 | $22.9K | 0 |
| Mar 16, 2023↗ | Donovan Michael Patrick | VP Operations | Sell | 2,769 | $8.27 | $22.9K | 0 |
| Mar 16, 2023↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 7,038 | $8.27 | $58.2K | 0 |
| Mar 16, 2023↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 4,270 | $8.27 | $35.3K | 0 |
| Mar 16, 2023↗ | Ottinger Bradley | General Counsel and CCO | Sell | 2,634 | $8.27 | $21.8K | 0 |
| Mar 16, 2023↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 3,907 | $8.27 | $32.3K | 0 |
| Jan 30, 2023↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 42,981 | $9.53 | $409.7K | 0 |
| Jan 25, 2023↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 62,818 | $10.10 | $634.3K | 0 |
| Dec 27, 2022↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 327 | $9.44 | $3.1K | 0 |
| Dec 27, 2022↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 10,971 | $9.44 | $103.6K | 0 |
| Dec 27, 2022↗ | Donovan Michael Patrick | VP Operations | Sell | 286 | $9.44 | $2.7K | 0 |
| Dec 27, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 649 | $9.44 | $6.1K | 0 |
| Dec 27, 2022↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 286 | $9.44 | $2.7K | 0 |
| Dec 27, 2022↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 286 | $9.44 | $2.7K | 0 |
| Dec 14, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 8,930 | $10.93 | $97.6K | 0 |
| Nov 16, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 10,649 | $11.88 | $126.5K | 0 |
| Nov 14, 2022↗ | Freitag Gregory Gene | Director | Sell | 13,000 | $12.74 | $165.6K | 0 |
| Nov 8, 2022↗ | Freitag Gregory Gene | Director | Sell | 13,000 | $12.50 | $162.5K | 0 |
| Aug 10, 2022↗ | Freitag Gregory Gene | Director | Sell | 8,886 | $9.70 | $86.2K | 0 |
| Aug 4, 2022↗ | Freitag Gregory Gene | Director | Sell | 37,046 | $10.54 | $390.6K | 0 |
| Jul 25, 2022↗ | Freitag Gregory Gene | Director | Sell | 30,296 | $9.26 | $280.5K | 0 |
| Jul 18, 2022↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 751 | $8.40 | $6.3K | 0 |
| Jul 18, 2022↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 405 | $8.40 | $3.4K | 0 |
| Jul 18, 2022↗ | Donovan Michael Patrick | VP Operations | Sell | 657 | $8.40 | $5.5K | 0 |
| Jul 18, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 947 | $8.40 | $8.0K | 0 |
| Jul 18, 2022↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 657 | $8.40 | $5.5K | 0 |
| Jul 18, 2022↗ | Sandberg Eric | Chief Commercial Officer | Sell | 1,125 | $8.40 | $9.4K | 0 |
| Jul 18, 2022↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 657 | $8.40 | $5.5K | 0 |
| Jul 18, 2022↗ | Zaderej Karen L. | CEO | Sell | 9,081 | $8.40 | $76.3K | 0 |
| Mar 16, 2022↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 2,447 | $7.97 | $19.5K | 0 |
| Mar 16, 2022↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 1,497 | $7.97 | $11.9K | 0 |
| Mar 16, 2022↗ | Donovan Michael Patrick | VP Operations | Sell | 1,512 | $7.97 | $12.1K | 0 |
| Mar 16, 2022↗ | Friedman Mark Louis | VP Regulatory Affairs & Policy | Sell | 1,502 | $7.97 | $12.0K | 0 |
| Mar 16, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 2,769 | $7.97 | $22.1K | 0 |
| Mar 16, 2022↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 3,239 | $7.97 | $25.8K | 0 |
| Mar 16, 2022↗ | Ottinger Bradley | General Counsel and CCO | Sell | 648 | $7.97 | $5.2K | 0 |
| Mar 16, 2022↗ | Sandberg Eric | Chief Commercial Officer | Sell | 1,512 | $7.97 | $12.1K | 0 |
| Mar 16, 2022↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 2,770 | $7.97 | $22.1K | 0 |
| Feb 15, 2022↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 447 | $8.42 | $3.8K | 0 |
| Feb 15, 2022↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 357 | $8.42 | $3.0K | 0 |
| Feb 15, 2022↗ | Donovan Michael Patrick | VP Operations | Sell | 205 | $8.42 | $1.7K | 0 |
| Feb 15, 2022↗ | Friedman Mark Louis | VP Regulatory Affairs & Policy | Sell | 357 | $8.42 | $3.0K | 0 |
| Feb 15, 2022↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 950 | $8.42 | $8.0K | 0 |
| Feb 15, 2022↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 400 | $8.42 | $3.4K | 0 |
| Feb 15, 2022↗ | Sandberg Eric | Chief Commercial Officer | Sell | 762 | $8.42 | $6.4K | 0 |
| Feb 15, 2022↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 400 | $8.42 | $3.4K | 0 |
| Dec 27, 2021↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 326 | $9.74 | $3.2K | 0 |
| Dec 27, 2021↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 187 | $9.74 | $1.8K | 0 |
| Dec 27, 2021↗ | Donovan Michael Patrick | VP Operations | Sell | 286 | $9.74 | $2.8K | 0 |
| Dec 27, 2021↗ | Friedman Mark Louis | VP Regulatory Affairs & Policy | Sell | 286 | $9.74 | $2.8K | 0 |
| Dec 27, 2021↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 648 | $9.74 | $6.3K | 0 |
| Dec 27, 2021↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 286 | $9.74 | $2.8K | 0 |
| Dec 27, 2021↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 286 | $9.74 | $2.8K | 0 |
| Dec 27, 2021↗ | Zaderej Karen L. | CEO | Sell | 1,752 | $9.74 | $17.1K | 0 |
| Dec 20, 2021↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 144 | $9.24 | $1.3K | 0 |
| Dec 20, 2021↗ | Donovan Michael Patrick | VP Operations | Sell | 95 | $9.24 | $877.80 | 0 |
| Dec 20, 2021↗ | Friedman Mark Louis | VP Regulatory Affairs & Policy | Sell | 95 | $9.24 | $877.80 | 0 |
| Dec 20, 2021↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 757 | $9.24 | $7.0K | 0 |
| Dec 20, 2021↗ | Zaderej Karen L. | CEO | Sell | 1,243 | $9.24 | $11.5K | 0 |
| Dec 15, 2021↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 4,171 | $8.80 | $36.7K | 0 |
| Aug 6, 2021↗ | Zaderej Karen L. | CEO | Sell | 41,000 | $18.47 | $757.2K | 0 |
| Jul 21, 2021↗ | Donovan Michael Patrick | VP Operations | Sell | 1,935 | $20.04 | $38.8K | 0 |
| Jul 19, 2021↗ | Billet Isabelle | Chief Strategy and BD Officer | Sell | 728 | $19.20 | $14.0K | 0 |
| Jul 19, 2021↗ | DeVinney Erick Wayne | VP Peripheral Nerve Science | Sell | 392 | $19.20 | $7.5K | 0 |
| Jul 19, 2021↗ | Donovan Michael Patrick | VP Operations | Sell | 637 | $19.20 | $12.2K | 0 |
| Jul 19, 2021↗ | Friedman Mark Louis | VP Regulatory Affairs & Policy | Sell | 637 | $19.20 | $12.2K | 0 |
| Jul 19, 2021↗ | MARIANI PETER J | EVP & Chief Financial Officer | Sell | 918 | $19.20 | $17.6K | 0 |
| Jul 19, 2021↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 637 | $19.20 | $12.2K | 0 |
| Jul 19, 2021↗ | Sandberg Eric | Chief Commercial Officer | Sell | 1,090 | $19.20 | $20.9K | 0 |
| Jul 19, 2021↗ | Scopelianos Angelo | Chief R&D Officer | Sell | 637 | $19.20 | $12.2K | 0 |
| Jul 19, 2021↗ | Zaderej Karen L. | CEO | Sell | 8,812 | $19.20 | $169.2K | 0 |
| Jun 17, 2021↗ | Freitag Gregory Gene | Director | Sell | 8,781 | $20.92 | $183.7K | 0 |
| Jun 4, 2021↗ | MARTINEZ MARIA D. | Chief Human Resources Officer | Sell | 2,652 | $18.86 | $50.0K | 0 |
| Feb 25, 2021↗ | Freitag Gregory Gene | Director | Sell | 24,000 | $22.06 | $529.4K | 0 |
AXGN Insiders
Similar Stocks to AXGN
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
MDT
Medtronic plc
$87.06-0.37%
$112.19B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.20+0.77%
$18.47B